| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer (NCT01905046) | Alliance for Clinical Trials in Oncology | 2015-11-23 |
| mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian (NCT02208375) | M.D. Anderson Cancer Center | 2014-11-11 |
| Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer (NCT01874184) | University of Washington | 2013-10-01 |
| Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01540565) | National Cancer Institute (NCI) | 2012-04-09 |
| S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer (NCT01097278) | SWOG Cancer Research Network | 2011-11-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer (NCT01219075) | University of Southern California | 2010-07-01 |
| ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors (NCT01154426) | National Cancer Institute (NCI) | 2010-05-01 |
| Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer (NCT00986206) | Women and Infants Hospital of Rhode Island | 2009-06-01 |
| Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (NCT00673335) | UNICANCER | 2008-05-01 |
| Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers (NCT00899145) | Gynecologic Oncology Group | 2008-05-01 |
| Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers (NCT00897455) | Gynecologic Oncology Group | 2008-04-01 |
| Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer (NCT00664781) | Cancer Research UK | 2007-12-01 |
| Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer (NCT00535119) | National Cancer Institute (NCI) | 2007-09-01 |
| Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer (NCT00321633) | University College London Hospitals | 2005-09-01 |
| Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries (NCT00098800) | University of Arizona | 2004-10-01 |
| Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease (NCT00080756) | City of Hope Medical Center | 2004-03-11 |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy (NCT00084370) | University of Alabama at Birmingham | 2002-06-01 |